From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
UCB
UCB is a drug company based in Brussels, Belgium. Its U.S. subsidiary agreed to plead guilty in June 2011 and pay more than $34 million related to allegations that it promoted its epilepsy drug Keppra for unapproved uses.
UCB began reporting payments on food, gifts, consulting payments, travel, speaking fees and other similar exchanges as of January 2012. UCB combines all categories into a single amount.
UCB's 2013 U.S. sales: $2 billion. Source: IMS Health.
See all UCB payments, or visit UCB's transparency page.
Notable drugs
Total Payments by State
| State | Total |
|---|---|
| Texas | $6,240,973 |
| California | $6,175,215 |
| New York | $5,597,353 |
| Florida | $4,611,113 |
| North Carolina | $4,160,724 |
| Pennsylvania | $2,194,078 |
| Ohio | $1,826,818 |
| Arizona | $1,664,371 |
| Michigan | $1,474,741 |
| Georgia | $1,440,882 |
| Illinois | $1,305,709 |
| New Jersey | $1,270,979 |
| Maryland | $1,220,037 |
| Tennessee | $1,195,858 |
| Colorado | $1,028,033 |
| Arkansas | $994,904 |
| Massachusetts | $978,127 |
| Alabama | $946,722 |
| Oklahoma | $946,479 |
| Missouri | $897,751 |
| Kentucky | $885,448 |
| Washington | $840,072 |
| Virginia | $710,278 |
| Connecticut | $670,332 |
| Louisiana | $656,402 |
| Minnesota | $636,569 |
| Wisconsin | $609,888 |
| Nebraska | $604,413 |
| Idaho | $515,279 |
| Indiana | $480,436 |
| West Virginia | $454,023 |
| South Carolina | $452,829 |
| Nevada | $436,081 |
| Utah | $281,462 |
| Iowa | $253,358 |
| Oregon | $251,160 |
| Kansas | $245,615 |
| District of Columbia | $230,625 |
| New Hampshire | $208,020 |
| Mississippi | $207,088 |
| Rhode Island | $173,511 |
| New Mexico | $147,900 |
| Puerto Rico | $90,907 |
| Vermont | $49,791 |
| Hawaii | $40,043 |
| South Dakota | $36,335 |
| Delaware | $34,876 |
| Montana | $34,832 |
| Maine | $30,772 |
| North Dakota | $9,739 |
| Wyoming | $4,070 |
| Alaska | $3,347 |
| [Unknown State] | $108 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.
